RxDoctor Payments Data

Dipty Mangla, MD

Pain Medicine · Aldan, PANPI 1801124870

Payments from drug & device makers

What this record shows

29 manufacturers reported payments, led by Medtronic at 38.5% of the total. Reporting peaked in 2023 at $3,466 and has fallen 59.4% since, to $1,407 in 2025.

$10,731in general payments, 2019–2025

Across 170 payments — averaging $63.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$4K
  • Si-bone, Inc.$1K
  • Stryker$1K
  • Boston Scientific$894
  • Nevro Corp.$581
  • Pacira Pharmaceuticals Incorporated$548
  • plus $2K from 23 others

What the payments were for

  • Travel & lodging$5,10948%
  • Food & beverage$5,62252%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,731 in reported general payments places this provider in the 85th percentile of 294 pain medicine providers in Pennsylvania.

See all pain medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$366,857
Medicare patients
378
Services billed
21,709

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin192$3,554
Lidocaine20$3,485
Cyclobenzaprine Hcl101$1,457
Pregabalin72$1,080
Amitriptyline Hcl41$894
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen55$749
Tramadol Hcl161$677
Meloxicam88$650
Oxycodone Hcl45$551
Ibuprofen20$538
Omeprazole28$519
Baclofen12$498
Tizanidine Hcl28$452
Celecoxib19$431
Duloxetine Hcl12$250

Paid to pharmacies, not to this prescriber.

Other pain medicine in Aldan

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →